Fundraising FoxCompany K Partners — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
CoBX Bio is a drug discovery company working in chemical proteomics.
BiotechDeep Tech
Co-investorsAtinum Investment Co. Ltd.Kiwoom InvestmentKB InvestmentKorea Investment PartnersSolidus Investment
MADDE provides 3D printing-based manufacturing services using silicon carbide (SiC) and metal materials, producing components for high-value industries including semiconductors, space, nuclear, and defense.
Advanced ManufacturingHardwareNew Materials
Co-investorsAtinum Investment Co. Ltd.DSC InvestmentIntervestSchmidt
Prazer Therapeutics develops therapeutics using Targeted Protein Degradation (TPD) technology, including its SPiDEM platform, in which small molecules selectively bind pathological proteins and activate the ubiquitin-proteasome system for their elimination.
BiotechDeep TechSeoul, KR
Co-investorsKiwoom InvestmentPremier PartnersSmilegate Investment
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.